
Sight Sciences Investor Relations Material
Latest events

Q1 2025
Sight Sciences
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Sight Sciences Inc
Access all reports
Sight Sciences, Inc. is a medical technology company focused on developing and commercializing treatments for eye diseases. The company's main business is centered around creating devices that address conditions affecting the eye, particularly in the areas of glaucoma and dry eye disease. Sight Sciences' products are designed to improve patient outcomes by offering minimally invasive solutions that target the underlying causes of these conditions. It serves the ophthalmology and optometry sectors, providing tools for healthcare professionals to enhance the treatment of common but serious eye health issues. The company is headquartered in Menlo Park, California, and its shares are listed on the NASDAQ.
Key slides for Sight Sciences Inc


Q2 2024
Sight Sciences Inc


Q4 2024
Sight Sciences Inc
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
SGHT
Country
🇺🇸 United States